SPY-001

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameSPY-001
Drug Alias NameSPY001SPY-001PR-011PR011SPY001-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIntegrin alpha-4/beta-7 antagonists
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, UlcerativeColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[30] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesParagon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeiersai Pharmaceutical Technology (Shanghai) Co LtdSpyre Therapeutics IncParagon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesColitis, UlcerativeColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A